With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...
The occlusion of the LAA has proven clinical benefit in the literature with significant reductions in short- and long-term stroke incidence[2]. Unfortunately, the Left Atrial Appendage Occlusion Study ...
Conformal Medical designed its CLAAS AcuForm left atrial appendage occlusion (LAAO) system to build upon the novel CLAAS device. It conforms and seals the LAA with its proprietary foam-based ...
The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs. VizAI. It also correctly identified more LVO-negative cases and detected more LVOs missed ...
The WATCHMAN device is an LAA-occlusion device. It blocks the LAA (a small area within the left atrium) and prevents clots that form there from breaking off to the brain and causing a stroke.
The WATCHMAN device is an LAA-occlusion device. It blocks the LAA (a small area within the left atrium) and prevents clots that form there from breaking off to the brain and causing a stroke.
are more likely to benefit from left atrial appendage occlusion (LAAO) compared with direct-acting oral anticoagulant (DOAC) therapy, according to a study published Feb. 12 in JACC: Clinical ...
In particular, Drs. Mason and Ekeruo discuss left atrial appendage occlusion procedures that can prevent strokes for patients with AF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback